NEW YORK (GenomeWeb News) – Life science firm MetaStat today said it has executed two additional license agreements covering patent applications and technology from the Albert Einstein College of Medicine at Yeshiva University.

The additional license agreements are for US Patent Application Nos. 12/998,237 and 11/659,514, as well as a provisional US patent application.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.